The Art of Value Investing
  • Home
  • TheArtofValueInvesting.com
  • #FAQ
  • Business Related Article
  • Investing
    • Investing Lessons [Advanced]
    • Investing Lessons [Beginners]
    • My Stocks Updates
    • Stock Analysis [Advanced]
    • Stocks Analysis [Simple]
  • My Take on World Events
  • Options Selling
  • Summary of Courses and Books
  • Top Articles
  • Uncategorized
Select Page
My Stock Update: Keppel DC REIT Q2 DPU up 3.1%– Will I Sell?

My Stock Update: Keppel DC REIT Q2 DPU up 3.1%– Will I Sell?

by Chris Lee | Jul 21, 2016 | My Stocks Updates, Stock Analysis [Advanced]

What Keppel DC REIT Do Keppel DC REIT (SGX: AJBU) is a Singapore-based real estate investment trust (REIT). It was established with the main investment strategy of investing in a portfolio of income-producing real estate assets. They are primarily used for data centre...
Mr. Lim Say Boon, Chief Investment Officer of DBS Wealth Management’s 8 Predictions for The 2nd Half 2016 Market Outlook

Mr. Lim Say Boon, Chief Investment Officer of DBS Wealth Management’s 8 Predictions for The 2nd Half 2016 Market Outlook

by Chris Lee | Jul 8, 2016 | Investing

This is what I have gathered from Mr Lim Say Boon, Chief Investment Officer of DBS Wealth Management’s 8 predictions for the 2nd half 2016 market outlook: Brexit will not break EU but will break European   stocks Global economy will continue to suffer and...
Valuing Mobile Telesystems (NYSE: MBT) Using H Dividend Discount Model

Valuing Mobile Telesystems (NYSE: MBT) Using H Dividend Discount Model

by Chris Lee | Jun 23, 2016 | My Stocks Updates, Stock Analysis [Advanced]

Summary MBT is a telecommunications company with more than 100,000,000 subscribers and is Russia’s largest mobile operator and has high payout ratio close to their Free Cash Flow– which warrant the use of dividend discount model (DDM) to value it H Dividend...
Keryx Biopharmaceuticals Went Up 11.87% On 2 June 2016– BUT Should It?

Keryx Biopharmaceuticals Went Up 11.87% On 2 June 2016– BUT Should It?

by Chris Lee | Jun 5, 2016 | Investing, Investing Lessons [Advanced], My Stocks Updates

Keryx Biopharmaceuticals (NASDAQ: KERX) As Part Of My Portfolio KERX is one of the more interesting stock in my portfolio– and it is also a growth stock that has the potential to be a multi-bagger. What is a multi-bagger? “A multibagger is an investment...
Here Is What I Learnt From Watching Money Monster

Here Is What I Learnt From Watching Money Monster

by Chris Lee | May 18, 2016 | Investing, Investing Lessons [Beginners]

I am a fan of George Clooney. The latest movie that he acted in is called Money Monster. This article aims to share what I have learnt from watching the movie– from the perspective of someone who love investing. Before I share with you the lessons that I learnt,...
Addition to My Family Portfolio- A Biotechnology ETF!

Addition to My Family Portfolio- A Biotechnology ETF!

by Chris Lee | May 6, 2016 | Stocks Analysis [Simple], Top Articles

One of the first stock that I bought was called iShares Nasdaq Biotechnology ETF (NASDAQ: IBB). I bought it on 5th February 2015 at $310.51 and sold it on 13th July 2015 at $380, netting a cool 21.39%. I like biotechnology stock and so far I have had good experience...
« Older Entries
Next Entries »